Unified classification and risk-stratification in Acute Myeloid Leukemia

Clinical recommendations for Acute Myeloid Leukemia (AML) classification and risk-stratification remain heavily reliant on cytogenetic findings at diagnosis, which are present in

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature communications 2022-08, Vol.13 (1), p.4622-4622, Article 4622
Hauptverfasser:	Tazi, Yanis, Arango-Ossa, Juan E., Zhou, Yangyu, Bernard, Elsa, Thomas, Ian, Gilkes, Amanda, Freeman, Sylvie, Pradat, Yoann, Johnson, Sean J., Hills, Robert, Dillon, Richard, Levine, Max F., Leongamornlert, Daniel, Butler, Adam, Ganser, Arnold, Bullinger, Lars, Döhner, Konstanze, Ottmann, Oliver, Adams, Richard, Döhner, Hartmut, Campbell, Peter J., Burnett, Alan K., Dennis, Michael, Russell, Nigel H., Devlin, Sean M., Huntly, Brian J. P., Papaemmanuil, Elli
Format:	Artikel
Sprache:	eng
Schlagworte:	631/208/69 631/67/69 692/4028/67/1990/283/1897 Acute myeloid leukemia Chemotherapy Classification Cytogenetic Analysis Cytogenetics Decision support systems Diagnosis Flow Cytometry - methods Humanities and Social Sciences Humans Induction Chemotherapy - methods Leukemia Leukemia, Myeloid, Acute - diagnosis Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - therapy Minimal residual disease multidisciplinary Mutation Neoplasm, Residual Patients Risk Science Science (multidisciplinary) Subgroups Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Clinical recommendations for Acute Myeloid Leukemia (AML) classification and risk-stratification remain heavily reliant on cytogenetic findings at diagnosis, which are present in
ISSN:	2041-1723 2041-1723
DOI:	10.1038/s41467-022-32103-8